HA
ARKG icon

Herold Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Herold Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,134
Closed -$52.1K – 213
2022
Q1 		$52.1K Buy
+1,134
New +$54.1K 0.02% 375
2021
Q4 		– Sell
-745
Closed -$55K – 222
2021
Q3 		$55K Buy
+745
New +$62.5K 0.02% 361

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Herold Advisors's ARKG Position: Q2 2022 in Review

Herold Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 1,134 shares — an estimated $52.1K sold.

Herold Advisors first reported a position in ARKG in Q3 2021 and held it in 2 quarters. The position peaked at $55K in Q3 2021. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

  • Herold Advisors reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
  • Herold Advisors sold 1,134 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $52.1K.
  • Herold Advisors first reported a position in ARK Genomic Revolution ETF in Q3 2021 and held it in 2 quarters.
  • Herold Advisors's ARK Genomic Revolution ETF position peaked at $55K in Q3 2021.
  • 333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Herold Advisors's 13F filing for Q2 2022, filed 15 Jul 2022.